As President and Chief Executive Officer, Brian Pereira oversees all aspects of Visterra and its interactions with the parent the company Otsuka, including research & development, accounting & finance, legal, pharmaceutical sciences & technology, operations, business development and strategy.
Brian Pereira joined Visterra in 2013 and is a veteran biopharmaceutical and healthcare leader with experience in financing and growing companies. Prior to joining Visterra, Brian served as the President and CEO of AMAG Pharmaceuticals where he raised four financing rounds at increasing valuations, and built the clinical development, manufacturing, supply-chain, and commercial infrastructure for Feraheme. Previously he held senior roles at Tufts Medical Center including President and CEO of a Tufts Medical Center Physician Organization, interim COO, Vice-Chairman for Strategic Development of the Department of Medicine, and staff physician. Brian serves on the Board of Directors of Africa Healthcare Network, KalVista, Cullinan Pearl, ProKidney and the American India Foundation. He was previously Chairman of the Board of Biodel, Abeona Therapeutics, NephroPlus, Africa Healthcare Network and the Harvard-MIT Biomedical Enterprise Program. He also served as President and Board member of the National Kidney Foundation and a member of the Boards of Tengion and Aksys. Brian is an Adjunct Professor of Medicine at Tufts University School of Medicine and has authored over 200 published scientific articles.
Brian received his medical degree (MBBS) from St. John’s Medical College, MD (Medicine) and DM (Nephrology) from the Post Graduate Institute, and MBA from Kellogg Graduate School of Management at Northwestern University.
